Literature DB >> 16861889

A novel link between SUMO modification and cancer metastasis.

Sung Hee Baek1.   

Abstract

SUMO (small ubiquitin-related modifier), a member of ubiquitin-like proteins, modifies a large number of transcription factors and coregulators. Although ubiquitin and SUMO exhibit structural similarities, the biological output of SUMOylation is somewhat distinct from protein degradation that is mainly mediated by ubiquitination. SUMOylation is involved in the regulation of the subcellular localization and stabilization of transcriptional cofactors and chromatin remodeling factors. Given the number of oncogenes and tumor suppressor genes that have been defined as targets for SUMOylation, studies on protein SUMOylation may shed light on the mechanism of tumorigenesis and metastasis. New roles of SUMOylation of a chromatin-remodeling complex have been elucidated. The SUMOylation status of the reptin chromatin-remodeling complex modulates the KAI1 metastasis suppressor gene and the invasive activity of cancer cells with metastatic potential; this revealed a novel link between SUMO modification and cancer metastasis. Here I overview these findings and discuss biological importance of protein SUMOylation in cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16861889     DOI: 10.4161/cc.5.14.3008

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  23 in total

1.  Role of the BCA2 ubiquitin E3 ligase in hormone responsive breast cancer.

Authors:  Angelika M Burger; Fathima Kona; Yutaka Amemiya; Yuguang Gao; Stephanie Bacopulos; Arun K Seth
Journal:  Open Cancer J       Date:  2010

2.  Mass spectral enhanced detection of Ubls using SWATH acquisition: MEDUSA--simultaneous quantification of SUMO and ubiquitin-derived isopeptides.

Authors:  John R Griffiths; Navin Chicooree; Yvonne Connolly; Milla Neffling; Catherine S Lane; Thomas Knapman; Duncan L Smith
Journal:  J Am Soc Mass Spectrom       Date:  2014-02-19       Impact factor: 3.109

Review 3.  Regulation of the sumoylation system in gene expression.

Authors:  Bin Liu; Ke Shuai
Journal:  Curr Opin Cell Biol       Date:  2008-05-28       Impact factor: 8.382

4.  Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner.

Authors:  S Zhu; M Sachdeva; F Wu; Z Lu; Y-Y Mo
Journal:  Oncogene       Date:  2009-12-21       Impact factor: 9.867

5.  High-level SAE2 promotes malignant phenotype and predicts outcome in gastric cancer.

Authors:  Duan-Fang Shao; Xiao-Hong Wang; Zi-Yu Li; Xiao-Fang Xing; Xiao-Jing Cheng; Ting Guo; Hong Du; Ying Hu; Bin Dong; Ning Ding; Lin Li; Shen Li; Qing-Da Li; Xian-Zi Wen; Lian-Hai Zhang; Jia-Fu Ji
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

6.  High-level SAE2 promotes malignant phenotype and predicts outcome in gastric cancer.

Authors:  Duan-Fang Shao; Xiao-Hong Wang; Zi-Yu Li; Xiao-Fang Xing; Xiao-Jing Cheng; Ting Guo; Hong Du; Ying Hu; Bin Dong; Ning Ding; Lin Li; Shen Li; Qing-Da Li; Xian-Zi Wen; Lian-Hai Zhang; Jia-Fu Ji
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

7.  Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9.

Authors:  Srinivasa Subramaniam; Robert G Mealer; Katherine M Sixt; Roxanne K Barrow; Alessandro Usiello; Solomon H Snyder
Journal:  J Biol Chem       Date:  2010-04-27       Impact factor: 5.157

Review 8.  Sumoylation and regulation of cardiac gene expression.

Authors:  Jun Wang; Robert J Schwartz
Journal:  Circ Res       Date:  2010-07-09       Impact factor: 17.367

Review 9.  Ubiquitin proteolytic system: focus on SUMO.

Authors:  Van G Wilson; Phillip R Heaton
Journal:  Expert Rev Proteomics       Date:  2008-02       Impact factor: 3.940

10.  Phorbol ester enhances KAI1 transcription by recruiting Tip60/Pontin complexes.

Authors:  Alexandra Rowe; Jörg Weiske; Tobias S Kramer; Otmar Huber; Paul Jackson
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.